GPT and metabolic dysfunction-associated steatotic liver disease: In the present study, we aimed to assess the effect of n-3 PUFAs supplementation in lowering liver fat, liver enzyme (alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyltransferase (GGT) levels), and blood lipid levels (TC, TG, HDL, and LDL) in patients with NAFLD.